title: Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream.
authors.affiliation: Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Leventhal
authors.affiliation: Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut.
authors.forename: Ian D
authors.initials: ID
authors.lastname: Odell
authors.affiliation: Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut; Department of Veterans Affairs, West Haven, Connecticut.
authors.forename: Suguru
authors.initials: S
authors.lastname: Imaeda
authors.affiliation: University of California, Davis, California.
authors.forename: Emanual
authors.initials: E
authors.lastname: Maverakis
authors.affiliation: Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut; Department of Veterans Affairs, West Haven, Connecticut.
authors.forename: Brett A
authors.initials: BA
authors.lastname: King
keywords: IL-2, interleukin-2; imiquimod; immunotherapy; interleukin-2; medical dermatology; melanoma; oncology